Question 1

What specific markers will be tested and what do they indicate about my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients clinical trial (NCT05201625). Contact the study team or your healthcare provider for specific answers.

Question 2

How will participating in this trial affect my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients clinical trial (NCT05201625). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or benefits of being part of this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients clinical trial (NCT05201625). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my privacy be protected during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients clinical trial (NCT05201625). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I decide to withdraw from the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients clinical trial (NCT05201625). Contact the study team or your healthcare provider for specific answers.

What this study is about